DUBLIN--(BUSINESS WIRE)--The "Global Macular Edema Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering. Macular Edema Pipeline Highlights - 2019 ...
OCS-01’s positive results in Stage 1 of the Phase 3 DIAMOND trial for diabetic macular edema (DME) were presented as a late-breaking abstract showing that the trial met primary and secondary endpoints ...
DIAMOND trial in Diabetic Macular Edema (DME) with topical OCS-01 met its stage 1 objective of validating the loading and maintenance dosing regimen designed to optimize OCS-01 efficacy potential with ...
SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Allegro Ophthalmics, LLC, a biotechnology company focused on the development of novel therapies to treat neovascular retinal diseases, today announced ...
Is It Relevant to Keep Advocating Visual Inspection of the Cervix With Acetic Acid for Primary Cervical Cancer Screening in Limited-Resource Settings? The Lilongwe pediatric KS staging classification ...
ZUG, Switzerland and BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully driven to save sight and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback